Review article · 2026 · Open access

Mechanisms and determinants of mRNA Lipid Nanoparticle biodistribution: From pharmacokinetics to clinical translation

Zakia Al-Hareth, César López‐Camacho

Bioengineering & Translational Medicine, e70183 · Published 7 October 2026 · DOI 10.1002/btm2.70183

Open PDFView at the publisherCite this paper

In brief

“Mechanisms and determinants of mRNA Lipid Nanoparticle biodistribution: From pharmacokinetics to clinical translation” is a 2026 review article by Zakia Al-Hareth and César López‐Camacho, published in Bioengineering & Translational Medicine. OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Bioengineering & Translational Medicine.

Citations
0
References
167
Authors
2

Abstract

Messenger RNA (mRNA) therapeutics formulated in lipid nanoparticles (LNPs) have transformed the field of nucleic acid medicine by enabling transient, programmable protein expression for vaccination, protein replacement, immunotherapy, and genome engineering. Extending their clinical success beyond vaccines requires a mechanistic understanding of where LNP components and mRNA travel, which cells they enter, where cargo is translated, and how each component is cleared. Such biodistribution outcomes are governed by a complex interplay between nanoparticle physicochemical properties, administration route, protein corona formation, host physiology, intracellular trafficking, and degradation. Importantly, the biodistribution of lipid components, intact mRNA, degraded RNA fragments, and translated proteins represents distinct yet interconnected biological processes that should not be interpreted interchangeably. Advances in molecular imaging, quantitative nucleic acid analysis, mass spectrometry, spatial and single-cell technologies, and pharmacokinetic modeling are improving their resolution across tissues and time. In parallel, rational lipid engineering, selective organ targeting, biodegradable ionizable lipids, ligand-directed delivery, and artificial intelligence-assisted design are expanding opportunities for tissue-specific delivery beyond the liver and lymphoid organs. However, interpretation remains constrained by assay heterogeneity, incomplete understanding of protein corona dynamics and endosomal escape, species-dependent differences, and the absence of harmonized regulatory standards. This review examines the mechanisms governing mRNA-LNP disposition, evaluates what current analytical methods detect and miss, synthesizes preclinical and clinical evidence, and considers the strategies needed to achieve predictable, tissue-selective, and clinically translatable mRNA delivery.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Al-Hareth, Z., & López‐Camacho, C. (2026). Mechanisms and determinants of mRNA Lipid Nanoparticle biodistribution: From pharmacokinetics to clinical translation. Bioengineering & Translational Medicine, e70183. https://doi.org/10.1002/btm2.70183

MLA 9

Al-Hareth, Zakia, and César López‐Camacho. “Mechanisms and determinants of mRNA Lipid Nanoparticle biodistribution: From pharmacokinetics to clinical translation.” Bioengineering & Translational Medicine, 2026, p. e70183. https://doi.org/10.1002/btm2.70183.

Chicago

Al-Hareth, Zakia and César López‐Camacho. 2026. “Mechanisms and determinants of mRNA Lipid Nanoparticle biodistribution: From pharmacokinetics to clinical translation.” Bioengineering & Translational Medicine: e70183. https://doi.org/10.1002/btm2.70183.

Harvard

Al-Hareth, Z. and López‐Camacho, C. (2026) ‘Mechanisms and determinants of mRNA Lipid Nanoparticle biodistribution: From pharmacokinetics to clinical translation’, Bioengineering & Translational Medicine, p. e70183. doi:10.1002/btm2.70183.

IEEE

Z. Al-Hareth and C. López‐Camacho, “Mechanisms and determinants of mRNA Lipid Nanoparticle biodistribution: From pharmacokinetics to clinical translation,” Bioengineering & Translational Medicine, p. e70183, 2026, doi: 10.1002/btm2.70183.

BibTeX

@article{alhareth2026mechanisms,
  title     = {{Mechanisms and determinants of mRNA Lipid Nanoparticle biodistribution: From pharmacokinetics to clinical translation}},
  author    = {Al-Hareth, Zakia and López‐Camacho, César},
  journal   = {Bioengineering \& Translational Medicine},
  year      = {2026},
  pages     = {e70183},
  doi       = {10.1002/btm2.70183},
  url       = {https://doi.org/10.1002/btm2.70183}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • mRNA lipid nanoparticles
  • pharmacokinetics
  • protein corona
  • endosomal escape
  • intracellular trafficking
  • ionizable lipids
  • tissue-specific delivery
  • nanoparticle clearance

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Al-Hareth, Z., & López‐Camacho, C. (2026). Mechanisms and determinants of mRNA Lipid Nanoparticle biodistribution: From pharmacokinetics to clinical translation. Bioengineering & Translational Medicine, e70183. https://doi.org/10.1002/btm2.70183

How many times has this paper been cited?

0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Bioengineering & Translational Medicine: sign in and open the PDF from this page.

Who wrote this paper?

Zakia Al-Hareth, César López‐Camacho.

What is the DOI of this paper?

10.1002/btm2.70183, permanently at https://doi.org/10.1002/btm2.70183. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.